Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2005
03/03/2005WO2005018414A2 Detection of somatic cells in milk
03/03/2005WO2005018331A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005WO2005000088A3 Expression profile of pancreatic cancer
03/03/2005WO2004113493A3 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
03/03/2005WO2004108071A3 Targeting polypeptides to the central nervous system
03/03/2005WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using
03/03/2005WO2004029212A3 In vivo gene silencing by chemically modified and stable sirna
03/03/2005WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals
03/03/2005US20050050588 Phloem small RNA binding protein (PSRB) for use in enhancing plant growth, systemic resistance, biomass distribution and flowering
03/03/2005US20050050586 AP1 amine oxidase variants
03/03/2005US20050049411 Exocyclic amine triaryl methyl protecting groups in two step polynucleotide synthesis
03/03/2005US20050049410 Expression vector comprising nucleotide sequences coding crystal protein for use as tool in controlling plant pest; pesticides; biological pest control
03/03/2005US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits
03/03/2005US20050049407 Sugar with heterocyclic base having exocyclic amine group and substituted or unsubstituted triaryl methyl protecting group bound to exocyclic amine group
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049211 Oligonucleotides for treating hyperproliferative diseases such as cancer, inflammatory, developmental or metabolic disorders
03/03/2005US20050049192 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/03/2005US20050049188 G protein couple receptor for identifying modulators for treatment of cancers, infection, respiratory, nervous system, eating and pain disorders
03/03/2005US20050048635 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same
03/03/2005US20050048634 Expression vector comprising nucleotide sequences coding methyltransferase for use as diagnostic screening tool in detecting antitumor/antiproliferative agents
03/03/2005US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
03/03/2005US20050048624 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
03/03/2005US20050048621 Using cytidine deaminase to generate variabilty in immunoglobulins; immunotherapy and directed protein evolution
03/03/2005US20050048620 Polynucleotides encoding a novel human neuronal cell adhesion protein, BGS-28, and variants thereof
03/03/2005US20050048617 Humanization of antibodies
03/03/2005US20050048613 Expression vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of lung and or colon tumors; antitumor agents
03/03/2005US20050048612 Human epidermal proteins HEP1-1 to HEP1-6
03/03/2005US20050048606 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/03/2005US20050048601 solid phase synthesis
03/03/2005US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy
03/03/2005US20050048577 Methods of using cytokine receptor zalpha11 to detect its ligands
03/03/2005US20050048556 Expression vector comprising nucleotide sequences coding polypeptides which confer herbicide resistance to plants; tissue engineering and biological pest comtrol
03/03/2005US20050048552 Higher order structure and binding of peptide nucleic acids
03/03/2005US20050048546 Coded metal nanoparticle comprising an oligonucleotide for use as diagnostic tool in identifying restriction fragment length polymorphisms and microorganismal genomic sequences
03/03/2005US20050048541 Using oligomeric sorting tags comprising repeat units and an increased affinity for stationary supports to separate preferential compounds within mixture; solid phase chemical synthesis
03/03/2005US20050048532 Oligonucleotide for use as diagnostic indicator of seauiterpene endoperoxide resistance in escherichia; identifying and designing modulators to prevent bacterial infection; drug screening
03/03/2005US20050048531 Microarray comprised of immobilized probses for use in detectnig genetic aberration; gene expression and analysis; identifying restriction fragment ength polymorphisms
03/03/2005US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders
03/03/2005US20050048517 Compositions and methods for polynucleotide detection
03/03/2005US20050048510 Aquifex aeolicus delta prime polymerase subunit and use thereof
03/03/2005US20050048508 Trehalose receptor and method for detecting trehalose with the same
03/03/2005US20050048502 Human SACH-related gene variants associated with cancers
03/03/2005US20050048497 Cleavable linker for polynucleotide synthesis
03/03/2005US20050048496 Concurrent oxidation, deprotection; solid phase synthesis
03/03/2005US20050048495 Antisense oligonucleotide for use in controlling galectin expression and treatment of infection, autoimmune, cardiovascular, nervous system, cell proliferative and inflammatory disorders
03/03/2005US20050048490 Cell growth, differentiation and death polypeptide (CGDD) for use in diagnosis, prevention and treatment of cell proliferative, developmental, neurological, autoimmune, inflammatory and reproductive disorders
03/03/2005US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder
03/03/2005US20050048487 Such as thrombin binding aptamer attached by terminal phosphate to amino sepharose via carbodiimide mediated coupling
03/03/2005US20050048475 Materials and methods for detection of enterovirus and norovirus
03/03/2005US20050048470 Expression vector comprising nucleotide sequences coding recombinase inhibitor for use in treatment and prevention of viral infcetion and diseases
03/03/2005US20050048075 Protein isolation
03/03/2005US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
03/03/2005US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide
03/03/2005CA2816222A1 Influenza hemagglutinin and neuraminidase variants
03/03/2005CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation
03/03/2005CA2535976A1 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005CA2535859A1 Endotheliase-2 ligands
03/03/2005CA2535753A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005CA2535516A1 Silencing of tgf-beta receptor type ii expression by sirna
03/03/2005CA2530821A1 Hiv immunogenic complexes
03/03/2005CA2529647A1 Influenza hemagglutinin and neuraminidase variants
03/03/2005CA2525619A1 Methods and compositions for rna interference
03/03/2005CA2523658A1 Rnai agents for anti-sars coronavirus therapy
03/02/2005EP1510523A1 Precurors for two-step polynucleotide synthesis
03/02/2005EP1510522A1 Method of polynucleotide synthesis using modified support
03/02/2005EP1509768A2 Methods for cohort selection and longevity studies
03/02/2005EP1509540A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/02/2005EP1451320A4 Materials and methods for releasing genetic material
03/02/2005EP1257695A4 Biomolecules having multiple attachment moieties for binding to a substrate surface
03/02/2005EP1179028B1 Solvent resistant photosensitive compositions
03/02/2005EP1027366B1 Synthesis of polynucleotides having random sequences
03/02/2005EP0919617B1 Anti-human mp52 monoclonal antibody
03/02/2005EP0833936A4 Alternative dye-labeled primers, ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated dna analysis and homogeneous amplification/detection assays
03/02/2005EP0783582B1 PROCESS OF PRODUCING $g(b)-LACTAM ANTIBIOTICS APPLYING MICROORGANISMS WITH INCREASED LIGASE ACTIVITY
03/02/2005CN1587408A Structure of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor
03/02/2005CN1587407A Si RNA capable of controlling foot-and-mouth disease virus copying and infection and its preparing method and use
03/02/2005CN1587406A SiRNA double chain for inhibiting bc 1-2 gen expression and use
03/02/2005CN1587385A High efficiency experssino human glicentin-1 gene engineering bacteria and its construction method and use
03/02/2005CN1191359C Nucleic acid sequence of high-molecuale glutanin 14 sub-unit gene of wheat and its application
03/02/2005CN1191270C Cellulose binding domain
03/02/2005CN1191268C Antisense oligonucleitde structure and use using serine/threonine kinase AIM-1 gene as target
03/02/2005CN1191267C Antisense oligonucleotide structure and use using serine/threonine kinase P[K] gene as target
03/01/2005US6861573 Comprises nucleotide sequences coding glycine rich polypeptide for use in generating genetically engineered disease resistant plants; biological pest control
03/01/2005US6861518 Hybrid oligonucleotide
03/01/2005US6861247 Salmonella secreted proteins and uses thereof
03/01/2005US6861241 Human kinase and polynucleotides encoding the same
03/01/2005US6861240 Human kinases and polynucleotides encoding the same
03/01/2005US6861221 Nanoparticles having oligonucleotides attached thereto and uses therefor
03/01/2005US6861216 Detecting complementary DNA fragments utilizing a combination of the conventional DNA micro-array and the conventional radiation image storage panel; almost free from noises caused by inadvertently fixed non-complementary DNA fragments
03/01/2005US6861214 Immobilization of biopolymers to aminated substrates by direct adsorption
02/2005
02/24/2005WO2005017188A2 Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response
02/24/2005WO2005017186A2 Method for rapid identification of alternative splicing
02/24/2005WO2005017183A2 Methylated gene biomarkers for detecting cancer
02/24/2005WO2005017167A1 Promoter molecules for use in plants
02/24/2005WO2005017156A1 A NEW CLASS OF α2δ CALCIUM CHANNEL SUBUNITS
02/24/2005WO2005017153A2 Methods for synthesis of defined polynucleotides
02/24/2005WO2005017150A1 Compositions and methods for prognosis and therapy of liver cancer
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 899